您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览0

Brain imaging is essential for the diagnosis and characterization of cerebral small vessel disease. Several magnetic resonance imaging markers have therefore emerged, providing new information on the diagnosis, progression, and mechanisms of small vessel disease. Yet, the reproducibility of these small vessel disease markers has received little attention despite being widely used in cross-sectional and longitudinal studies. This review focuses on the main small vessel disease-related markers on magnetic resonance imaging including: white matter hyperintensities, lacunes, dilated perivascular spaces, microbleeds, and brain volume. The aim is to summarize, for each marker, what is currently known about: (1) its reproducibility in studies with a scan-rescan procedure either in single or multicenter settings; (2) the acquisition-related sources of variability; and, (3) the techniques used to minimize this variability. Based on the results, we discuss technical and other challenges that need to be overcome in order for these markers to be reliably used as outcome measures in future clinical trials. We also highlight the key points that need to be considered when designing multicenter magnetic resonance imaging studies of small vessel disease.

作者:Fran?ois, De Guio;Eric, Jouvent;Geert Jan, Biessels;Sandra E, Black;Carol, Brayne;Christopher, Chen;Charlotte, Cordonnier;Frank-Eric, De Leeuw;Martin, Dichgans;Fergus, Doubal;Marco, Duering;Carole, Dufouil;Emrah, Duzel;Franz, Fazekas;Vladimir, Hachinski;M Arfan, Ikram;Jennifer, Linn;Paul M, Matthews;Bernard, Mazoyer;Vincent, Mok;Bo, Norrving;John T, O'Brien;Leonardo, Pantoni;Stefan, Ropele;Perminder, Sachdev;Reinhold, Schmidt;Sudha, Seshadri;Eric E, Smith;Luciano A, Sposato;Blossom, Stephan;Richard H, Swartz;Christophe, Tzourio;Mark, van Buchem;Aad, van der Lugt;Robert, van Oostenbrugge;Meike W, Vernooij;Anand, Viswanathan;David, Werring;Frank, Wollenweber;Joanna M, Wardlaw;Hugues, Chabriat

来源:Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2016 年 36卷 8期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:0
作者:
Fran?ois, De Guio;Eric, Jouvent;Geert Jan, Biessels;Sandra E, Black;Carol, Brayne;Christopher, Chen;Charlotte, Cordonnier;Frank-Eric, De Leeuw;Martin, Dichgans;Fergus, Doubal;Marco, Duering;Carole, Dufouil;Emrah, Duzel;Franz, Fazekas;Vladimir, Hachinski;M Arfan, Ikram;Jennifer, Linn;Paul M, Matthews;Bernard, Mazoyer;Vincent, Mok;Bo, Norrving;John T, O'Brien;Leonardo, Pantoni;Stefan, Ropele;Perminder, Sachdev;Reinhold, Schmidt;Sudha, Seshadri;Eric E, Smith;Luciano A, Sposato;Blossom, Stephan;Richard H, Swartz;Christophe, Tzourio;Mark, van Buchem;Aad, van der Lugt;Robert, van Oostenbrugge;Meike W, Vernooij;Anand, Viswanathan;David, Werring;Frank, Wollenweber;Joanna M, Wardlaw;Hugues, Chabriat
来源:
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2016 年 36卷 8期
标签:
Magnetic resonance imaging atrophy brain volume cerebral small vessel disease lacunes marker microbleeds perivascular spaces repeatability reproducibility variability white matter hyperintensities
Brain imaging is essential for the diagnosis and characterization of cerebral small vessel disease. Several magnetic resonance imaging markers have therefore emerged, providing new information on the diagnosis, progression, and mechanisms of small vessel disease. Yet, the reproducibility of these small vessel disease markers has received little attention despite being widely used in cross-sectional and longitudinal studies. This review focuses on the main small vessel disease-related markers on magnetic resonance imaging including: white matter hyperintensities, lacunes, dilated perivascular spaces, microbleeds, and brain volume. The aim is to summarize, for each marker, what is currently known about: (1) its reproducibility in studies with a scan-rescan procedure either in single or multicenter settings; (2) the acquisition-related sources of variability; and, (3) the techniques used to minimize this variability. Based on the results, we discuss technical and other challenges that need to be overcome in order for these markers to be reliably used as outcome measures in future clinical trials. We also highlight the key points that need to be considered when designing multicenter magnetic resonance imaging studies of small vessel disease.